Jane Harness
Chief Tech/Sci/R&D Officer at INNOVATION PHARMACEUTICALS INC.
Net worth: 489 $ as of 29/04/2024
Jane Harness active positions
Companies | Position | Start | End |
---|---|---|---|
INNOVATION PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 31/08/2016 | - |
Corporate Officer/Principal | 31/08/2016 | - |
Career history of Jane Harness
Former positions of Jane Harness
Companies | Position | Start | End |
---|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31/12/2009 | 31/12/2013 |
REVANCE THERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2014 | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Training of Jane Harness
University of Leicester | Graduate Degree |
University of Aberdeen | Graduate Degree |
Statistics
International
United States | 5 |
United Kingdom | 3 |
Operational
Corporate Officer/Principal | 4 |
Graduate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
INNOVATION PHARMACEUTICALS INC. | Health Technology |
PFIZER, INC. | Health Technology |
REVANCE THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Jane Harness
- Experience